This prolonged tumor localization suggests high affinity for the target receptor (CCK2R) and excellent tumor retention, demonstrating the effectiveness of [177Lu]Lu-DOTA-CCK2R-dimer for in vivo imaging applications and providing support for targeted radionuclide therapy. Here, CCKBR is linked to neoplasm.